MRI breast cancer screening compared to mammography in women with a familial risk: A multicenter randomized controlled trial

被引：1
|
作者：
Tilanus-Linthorst, M. M.
Saadatmand, S.
Geuzinge, A. H.
Rutgers, E. J.
Mann, R.
van Zuidewijn, D. B. de Roy
Zonderland, H. M.
Tollenaar, R. A.
Lobbes, M. B.
Ausems, M. G.
van't Riet, M.
Hooning, M. J.
Mares-Engelbert, I.
Luiten, E. J.
Heijnsdijk, E. A.
Verhoef, C.
Karssemeijer, N.
Oosterwijk, J. C.
Obdeijn, I-M
de Koning, H. J.
机构：
[1] Erasmus Univ, Med Ctr, Rotterdam, Netherlands
[2] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Amsterdam, Netherlands
[3] Catholic Univ Nijmegen, Nijmegen, Netherlands
[4] Med Ctr Leeuwarden, Leeuwarden, Netherlands
[5] Amsterdam Univ Med Ctr, Amsterdam, Netherlands
[6] Leiden Univ, Med Ctr, Leiden, Netherlands
[7] Maastricht Maastricht, Acad Hosp, Maastricht, Netherlands
[8] Univ Med Ctr, Utrecht, Netherlands
[9] Reinier de Graaf Gasthuis, Delft, Netherlands
[10] Vlietland Ziekenhuis, Schiedam, Netherlands
[11] Amphia Ziekenhuis, Breda, Netherlands
[12] Univ Med Ctr Groningen, Groningen, Netherlands
来源：
CANCER RESEARCH | 2019年 / 79卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS18-P6-13-01
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P6-13-01
引用
收藏
页数：3
相关论文
共 50 条
  • [1] MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trial
    Saadatmand, Sepideh
    Geuzinge, H. Amarens
    Rutgers, Emiel J. T.
    Mann, Ritse M.
    van Zuidewijn, Diderick B. W. de Roy
    Zonderland, Harmien M.
    Tollenaar, Rob A. E. M.
    Lobbes, Marc B., I
    Ausems, Margreet G. E. M.
    van t'Riet, Martijne
    Hooning, Maartje J.
    Mares-Engelberts, Ingeborg
    Luiten, Ernest J. T.
    Heijnsdijk, Eveline A. M.
    Verhoef, Cees
    Karssemeijer, Nico
    Oosterwijk, Jan C.
    Obdeijn, Inge-Marie
    de Koning, Harry J.
    Tilanus-Linthorst, Madeleine M. A.
    [J]. LANCET ONCOLOGY, 2019, 20 (08): : 1136 - 1147
  • [2] Costs and effects in the first randomized trial comparing MRI breast cancer screening with mammography in women with a familial risk: FaMRIsc
    Tilanus-Linthorst, Madeleine M. A.
    Geuzinge, H. Amarens
    Obdeijn, Inge-Marie M.
    Rutgers, Emiel J. T.
    Mann, Ritse M.
    Saadatmand, Sepideh
    van Zuidewijn, Diderick B. W. de Roy
    Tollenaar, Robert A. E. M.
    Lobbes, Marc B. I.
    Ausems, Margreet G. E. M.
    van't Riet, Martijne
    Hooning, Maartje J.
    Wesseling, Jelle
    Mares-Engelberts, Ingeborg
    Luiten, Ernest J. T.
    Oosterwijk, Jan C.
    Heijnsdijk, Eveline A. M.
    de Koning, Harry J.
    [J]. CANCER RESEARCH, 2020, 80 (04)
  • [3] Breast density as indicator for the use of mammography or MRI to screen women with familial risk for breast cancer (FaMRIsc): a multicentre randomized controlled trial
    Saadatmand, Sepideh
    Rutgers, Emiel J. T.
    Tollenaar, Rob A. E. M.
    Zonderland, Hermien M.
    Ausems, Margreet G. E. M.
    Keymeulen, Kristien B. M. I.
    Schlooz-Vries, Margreet S.
    Koppert, Linetta B.
    Heijnsdijk, Eveline A. M.
    Seynaeve, Caroline
    Verhoef, Cees
    Oosterwijk, Jan C.
    Obdeijn, Inge-Marie
    de Koning, Harry J.
    Tilanus-Linthorst, Madeleine M. A.
    [J]. BMC CANCER, 2012, 12
  • [4] Breast density as indicator for the use of mammography or MRI to screen women with familial risk for breast cancer (FaMRIsc): a multicentre randomized controlled trial
    Sepideh Saadatmand
    Emiel J T Rutgers
    RobAEM Tollenaar
    Hermien M Zonderland
    MargreetGEM Ausems
    KristienBMI Keymeulen
    Margreet S Schlooz-Vries
    Linetta B Koppert
    Eveline A M Heijnsdijk
    Caroline Seynaeve
    Cees Verhoef
    Jan C Oosterwijk
    Inge-Marie Obdeijn
    Harry J de Koning
    Madeleine M A Tilanus-Linthorst
    [J]. BMC Cancer, 12
  • [5] MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc)
    Narod, Steven A.
    [J]. LANCET ONCOLOGY, 2019, 20 (09): : E465 - E465
  • [6] Cost-effective strategies according to the first randomized trial comparing MRI breast cancer screening with mammography in women with a familial risk: FaMRIsc
    Tilanus-Linthorst, M.
    Geuzinge, A.
    Obdeijn, A. I. M.
    Rutgers, E.
    Mann, R.
    Saadatmand, S.
    van Zuidewijn, D. de Roy
    Tollenaar, R.
    Lobbes, M.
    Ausems, M.
    van 't Riet, M.
    Hooning, M.
    Luiten, E.
    Loo, C.
    Wesseling, J.
    Verhoef, C.
    Oosterwijk, J. G.
    Heijnsdijk, E.
    de Koning, H.
    [J]. EUROPEAN JOURNAL OF CANCER, 2020, 138 : S2 - S2
  • [7] MRI versus Mammography plus Ultrasound in Women at Intermediate Breast Cancer Risk: Study Design and Protocol of the MRIB Multicenter, Randomized, Controlled Trial
    Bonelli, Luigina Ada
    Calabrese, Massimo
    Belli, Paolo
    Corcione, Stefano
    Losio, Claudio
    Montemezzi, Stefania
    Pediconi, Federica
    Petrillo, Antonella
    Zuiani, Chiara
    Camera, Lucia
    Carbonaro, Luca Alessandro
    Cozzi, Andrea
    Alfano, Daniele De Falco
    Gristina, Licia
    Panzeri, Marta
    Poire, Ilaria
    Schiaffino, Simone
    Tosto, Simona
    Trecate, Giovanna
    Trimboli, Rubina Manuela
    Valdora, Francesca
    Vigano, Sara
    Sardanelli, Francesco
    [J]. DIAGNOSTICS, 2021, 11 (09)
  • [8] UKCCCR MULTICENTER RANDOMIZED CONTROLLED TRIAL OF ONE AND 2 VIEW MAMMOGRAPHY IN BREAST-CANCER SCREENING
    WALD, NJ
    MURPHY, P
    MAJOR, P
    PARKES, C
    TOWNSEND, J
    FROST, C
    [J]. BRITISH MEDICAL JOURNAL, 1995, 311 (7014): : 1189 - 1193
  • [9] Experiences, expectations and preferences regarding MRI and mammography as breast cancer screening tools in women at familial risk
    Geuzinge, H. Amarens
    Heijnsdijk, Eveline A. M.
    Obdeijn, Inge-Marie
    de Koning, Harry J.
    Tilanus-Linthorst, Madeleine M. A.
    [J]. BREAST, 2021, 56 : 1 - 6
  • [10] MRI screening for breast cancer in women with high familial risk
    Kriege, M
    Brekelmans, C
    Boetes, C
    Rutgers, E
    Oosterwijk, J
    Tollenaar, R
    Manoliu, R
    Holland, R
    De Koning, H
    Klijn, J
    [J]. EUROPEAN JOURNAL OF CANCER, 2002, 38 : S51 - S51
12345